EXPLORE MORE CATEGORIES
- Home
- ยป
- What We Offer
- »
- Injection
Injection
Offering you a complete choice of products which include clexane enoxaparin injection 40 mg, eprex / 4000, zienam, wepox, metalyse and act hib.
Clexane Enoxaparin Injection 40 mg
Get Latest Price
Product Details:
| Number of Syringe | 2 Pre-Filled Syringe |
| Dosage/Strength | 40 mg/0.4 ml |
| Brand | Clexane |
| Drug Type | Anticoagulant Drug |
| Composition(Salt) | Enoxaparin Sodium |
| Manufacturer Name | SANOFI |
| Prescription/ Non Prescription | Prescription |
| Usage | Treatment and prevention of blood clots |
Get Best QuoteRequest A Callback
Eprex / 4000
Get Latest Price
JOHNSON & JOHNSON
"Our company offers optimum quality Eprex 2000 IU Inj (Epoetin) to the honored customers. These injections are formulated from good quality ingredients under the technical supervision of an expert team. Offered injections are used to produce red blood cells in the body. These injections are prescribed for the treatment of anemia.
Features:
Compositional accuracy
Pure composition
Longer shelf life"
ANTI ANEMIC
"Our company offers optimum quality Eprex 2000 IU Inj (Epoetin) to the honored customers. These injections are formulated from good quality ingredients under the technical supervision of an expert team. Offered injections are used to produce red blood cells in the body. These injections are prescribed for the treatment of anemia.
Features:
Compositional accuracy
Pure composition
Longer shelf life"
ANTI ANEMIC
Get Best QuoteRequest A Callback
Zienam
Get Latest Price
Product Details:
| Dose | 1ml-5ml |
| Injectable Form | Solution |
| Application | Anti Infective & Common Disease Medicines, Analgesics and Pain Relief Medicines |
| Injection Site | Intramuscular, Intravenous |
| Packaging Type | Glass Bottle |
| Medicine Type | Allopathic |
| Packaging Size | 500 mg |
| Usage | Clinical, Hospital |
"Zienam -500 mg Injection
Zienam ( 500 mg )
Our organization is offering a high grade of Zienam that are available in international standard packing and made from a premium quality of ingridients by our experienced engineers. These medicines are available in a number of countries with a variety of applications and known for its quick action to the diseases and accuracy in compositions. Moreover these products are available with a precise composition and safe usage and with a market leading price."
Get Best QuoteRequest A Callback
Wepox
Get Latest Price
JOHNSON & JOHNSON
"We hold expertise in providing a wide range of Wepox 4000 IU Injection (Rhu-erythropoietin). These are prepared in hygienic environment and with proper measure in formulating them. Our entire product range is treasured among them for its long shelf life and effective results. "
ANTI ANEMIC
"We hold expertise in providing a wide range of Wepox 4000 IU Injection (Rhu-erythropoietin). These are prepared in hygienic environment and with proper measure in formulating them. Our entire product range is treasured among them for its long shelf life and effective results. "
ANTI ANEMIC
Get Best QuoteRequest A Callback
Metalyse
Get Latest Price
BOEHRINGER INGELHEIM
"Metalyse is the brand name of yourmedicine. It comes as a sterile white to offwhite powder in clear glass vials. Metalyse powder must be mixed with sterile water for injections before use.
When mixed, the resulting solution is colourless to pale yellow. Metalyse is sold as a pack containing one vial of powder and one pre-filled syringe of sterile water for injections. " CARDIOVASCULAR - ACUTE MYOCARDIAL INFARCTION
"Metalyse is the brand name of yourmedicine. It comes as a sterile white to offwhite powder in clear glass vials. Metalyse powder must be mixed with sterile water for injections before use.
When mixed, the resulting solution is colourless to pale yellow. Metalyse is sold as a pack containing one vial of powder and one pre-filled syringe of sterile water for injections. " CARDIOVASCULAR - ACUTE MYOCARDIAL INFARCTION
Get Best QuoteRequest A Callback
ACT HIB
Get Latest Price
SANOFI PASTEUR
"ActHIB ®, Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), produced by Sanofi Pasteur SA, is a sterile, lyophilized powder which is reconstituted with either saline diluent (0.4% Sodium Chloride) or Tripedia®, Sanofi Pasteur Inc. Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP) (when reconstituted known as TriHIBit®) for intramuscular administration only. The vaccine consists of the Haemophilus b capsular polysaccharide (polyribosyl-ribitol-phosphate, PRP), a high molecular weight polymer prepared from the Haemophilus influenzae type b (Hib) strain 1482 grown in a semi-synthetic medium, covalently bound to tetanus toxoid.1 The lyophilized ActHIB vaccine powder and saline diluent contain no preservative. The tetanus toxoid is prepared by extraction, ammonium sulfate purification, and formalin inactivation of the toxin from cultures of Clostridium tetani (Harvard strain) grown in a modified Mueller and Miller medium.2 The culture medium contains milk derived raw materials (casein derivatives). Further manufacturing process steps reduce residual formaldehyde to levels below 0.5 micrograms (mcg) per dose by calculation. The toxoid is filter sterilized prior to the conjugation process. Potency of ActHIB vaccine is specified on each lot by limits on the content of PRP polysaccharide and protein in each dose and the proportion of polysaccharide and protein in the vaccine which is characterized as high molecular weight conjugate.
When ActHIB is reconstituted with saline diluent (0.4% Sodium Chloride), each 0.5 mL dose is formulated to contain 10 mcg of purified capsular polysaccharide conjugated to 24 mcg of inactivated tetanus toxoid, and 8.5% of sucrose.
When ActHIB is reconstituted with Tripedia vaccine to formulate TriHIBit vaccine, each 0.5 mL dose contains10 mcg of purified capsular polysaccharide conjugated to 24 mcg of inactivated tetanus toxoid, 8.5% of sucrose, 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid, and 46.8 mcg of pertussis antigens. Tripedia vaccine (vial presentation 0.6 mL) is formulated without preservatives but contains a trace amount of thimerosal [(mercury derivative), ( ≤ 0.3 mcg mercury/dose)] from the manufacturing process. (Refer to product insert for Tripedia vaccine.)" INFLUENZA VACCINE
"ActHIB ®, Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate), produced by Sanofi Pasteur SA, is a sterile, lyophilized powder which is reconstituted with either saline diluent (0.4% Sodium Chloride) or Tripedia®, Sanofi Pasteur Inc. Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed (DTaP) (when reconstituted known as TriHIBit®) for intramuscular administration only. The vaccine consists of the Haemophilus b capsular polysaccharide (polyribosyl-ribitol-phosphate, PRP), a high molecular weight polymer prepared from the Haemophilus influenzae type b (Hib) strain 1482 grown in a semi-synthetic medium, covalently bound to tetanus toxoid.1 The lyophilized ActHIB vaccine powder and saline diluent contain no preservative. The tetanus toxoid is prepared by extraction, ammonium sulfate purification, and formalin inactivation of the toxin from cultures of Clostridium tetani (Harvard strain) grown in a modified Mueller and Miller medium.2 The culture medium contains milk derived raw materials (casein derivatives). Further manufacturing process steps reduce residual formaldehyde to levels below 0.5 micrograms (mcg) per dose by calculation. The toxoid is filter sterilized prior to the conjugation process. Potency of ActHIB vaccine is specified on each lot by limits on the content of PRP polysaccharide and protein in each dose and the proportion of polysaccharide and protein in the vaccine which is characterized as high molecular weight conjugate.
When ActHIB is reconstituted with saline diluent (0.4% Sodium Chloride), each 0.5 mL dose is formulated to contain 10 mcg of purified capsular polysaccharide conjugated to 24 mcg of inactivated tetanus toxoid, and 8.5% of sucrose.
When ActHIB is reconstituted with Tripedia vaccine to formulate TriHIBit vaccine, each 0.5 mL dose contains10 mcg of purified capsular polysaccharide conjugated to 24 mcg of inactivated tetanus toxoid, 8.5% of sucrose, 6.7 Lf of diphtheria toxoid, 5 Lf of tetanus toxoid, and 46.8 mcg of pertussis antigens. Tripedia vaccine (vial presentation 0.6 mL) is formulated without preservatives but contains a trace amount of thimerosal [(mercury derivative), ( ≤ 0.3 mcg mercury/dose)] from the manufacturing process. (Refer to product insert for Tripedia vaccine.)" INFLUENZA VACCINE
Get Best QuoteRequest A Callback
Rhogam
Get Latest Price
JOHNSON AND JOHNSON
"Pregnancy and Other Obstetrical Conditions in Rh-Negative Women, Unless the Father or Baby are Conclusively Rh Negative Pregnancy/delivery of an Rh-positive baby irrespective of the ABO groups of the mother and baby Abortion/threatened abortion at any stage of gestation
Ectopic pregnancy Antepartum fetal-maternal hemorrhage (suspected or proven) resulting from antepartum hemorrhage (e.g., placenta previa), amniocentesis, chorionic villus sampling, percutaneous umbilical blood sampling, other obstetrical manipulative procedure (e.g., version) or abdominal trauma Transfusion of Rh incompatible blood or blood products Transfusion
Prevention of Rh immunization in any Rh-negative person after incompatible transfusion of Rh-positive blood or blood products (e.g., red blood cells, platelet concentrates, granulocyte concentrates)
ANTI ANEMIC
"Pregnancy and Other Obstetrical Conditions in Rh-Negative Women, Unless the Father or Baby are Conclusively Rh Negative Pregnancy/delivery of an Rh-positive baby irrespective of the ABO groups of the mother and baby Abortion/threatened abortion at any stage of gestation
Ectopic pregnancy Antepartum fetal-maternal hemorrhage (suspected or proven) resulting from antepartum hemorrhage (e.g., placenta previa), amniocentesis, chorionic villus sampling, percutaneous umbilical blood sampling, other obstetrical manipulative procedure (e.g., version) or abdominal trauma Transfusion of Rh incompatible blood or blood products Transfusion
Prevention of Rh immunization in any Rh-negative person after incompatible transfusion of Rh-positive blood or blood products (e.g., red blood cells, platelet concentrates, granulocyte concentrates)
ANTI ANEMIC
Get Best QuoteRequest A Callback
Integrilin 20/10Mg Inj
Get Latest Price
MERCK SCHERING PLOUGH
CARDIOVASCULAR - ACUTE MYOCARDIAL INFARCTION
CARDIOVASCULAR - ACUTE MYOCARDIAL INFARCTION
Get Best QuoteRequest A Callback
Arixtra
Get Latest Price
GSK
"ARIXTRA® is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE):
in patients undergoing hip fracture surgery, including extended prophylaxis;
in patients undergoing hip replacement surgery;
in patients undergoing knee replacement surgery;
in patients undergoing abdominal surgery who are at risk for thromboembolic complications.
Treatment Of Acute Deep Vein Thrombosis
ARIXTRA is indicated for the treatment of acute deep vein thrombosis when administered in conjunction with sodium.
Treatment Of Acute Pulmonary Embolism
ARIXTRA is indicated for the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital."
ANTI THROMBOTIC
"ARIXTRA® is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE):
in patients undergoing hip fracture surgery, including extended prophylaxis;
in patients undergoing hip replacement surgery;
in patients undergoing knee replacement surgery;
in patients undergoing abdominal surgery who are at risk for thromboembolic complications.
Treatment Of Acute Deep Vein Thrombosis
ARIXTRA is indicated for the treatment of acute deep vein thrombosis when administered in conjunction with sodium.
Treatment Of Acute Pulmonary Embolism
ARIXTRA is indicated for the treatment of acute pulmonary embolism when administered in conjunction with warfarin sodium when initial therapy is administered in the hospital."
ANTI THROMBOTIC
Get Best QuoteRequest A Callback
Abelcet
Get Latest Price
ENZON
"ABELCET® (amphotericin b) is a sterile, pyrogen-free suspension for intravenous infusion. ABELCET® consists of amphotericin B complexed with two phospholipids in a 1:1 drug-to-lipid molar ratio. The two phospholipids, L-α-dimyristoylphosphatidylcholine (DMPC) and L-α-dimyristoylphosphatidylglycerol (DMPG), are present in a 7:3 molar ratio. ABELCET® (amphotericin b) is yellow and opaque in appearance, with a pH of 5 - 7.
NOTE: Liposomal encapsulation or incorporation in a lipid complex can substantially affect a drug's functional properties relative to those of the unencapsulated or nonlipid-associated drug. In addition, different liposomal or lipid-complexed products with a common active ingredient may vary from one another in the chemical composition and physical form of the lipid component. Such differences may affect functional properties of these drug products.
Amphotericin B is a polyene, antifungal antibiotic produced from a strain of Streptomyces nodosus. Amphotericin B is designated chemically as [1R-(1R*, 3S*, 5R*, 6R*, 9R*, 11R*, 15S*, 16R*, 17R*, 18S*, 19E, 21E, 23E, 25E, 27E, 29E, 31E, 33R*, 35S*, 36R*, 37S*)]-33-[(3-Amino-3, 6-dideoxy-β-D-mannopyranosyl) oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicy-clo[33.3.1] nonatriaconta-19, 21, 23, 25, 27, 29, 31-heptaene-36-carboxylic acid.
It has a molecular weight of 924.09 and a molecular formula of C47H73NO17. The structural formula is:
ABELCET® (Amphotericin B Lipid Complex) Structural Formula Illustration
ABELCET® (amphotericin b) is provided as a sterile, opaque suspension in 20 mL glass, single-use vials. Each 20 mL vial contains 100 mg of amphotericin B (see DOSAGE AND ADMINISTRATION), and each mL of ABELCET® contains:
Amphotericin B USP.......................................5 mgL-α-dimyristoylphosphatidylcholine (DMPC).......................................3.4 mg
L-α-dimyristoylphosphatidylglycerol (DMPG).......................................1.5 mg
Sodium Chloride USP.......................................9 mg
Water for Injection USP, q.s. 1 mL "
ONCOLOGY
"ABELCET® (amphotericin b) is a sterile, pyrogen-free suspension for intravenous infusion. ABELCET® consists of amphotericin B complexed with two phospholipids in a 1:1 drug-to-lipid molar ratio. The two phospholipids, L-α-dimyristoylphosphatidylcholine (DMPC) and L-α-dimyristoylphosphatidylglycerol (DMPG), are present in a 7:3 molar ratio. ABELCET® (amphotericin b) is yellow and opaque in appearance, with a pH of 5 - 7.
NOTE: Liposomal encapsulation or incorporation in a lipid complex can substantially affect a drug's functional properties relative to those of the unencapsulated or nonlipid-associated drug. In addition, different liposomal or lipid-complexed products with a common active ingredient may vary from one another in the chemical composition and physical form of the lipid component. Such differences may affect functional properties of these drug products.
Amphotericin B is a polyene, antifungal antibiotic produced from a strain of Streptomyces nodosus. Amphotericin B is designated chemically as [1R-(1R*, 3S*, 5R*, 6R*, 9R*, 11R*, 15S*, 16R*, 17R*, 18S*, 19E, 21E, 23E, 25E, 27E, 29E, 31E, 33R*, 35S*, 36R*, 37S*)]-33-[(3-Amino-3, 6-dideoxy-β-D-mannopyranosyl) oxy]-1,3,5,6,9,11,17,37-octahydroxy-15,16,18-trimethyl-13-oxo-14,39-dioxabicy-clo[33.3.1] nonatriaconta-19, 21, 23, 25, 27, 29, 31-heptaene-36-carboxylic acid.
It has a molecular weight of 924.09 and a molecular formula of C47H73NO17. The structural formula is:
ABELCET® (Amphotericin B Lipid Complex) Structural Formula Illustration
ABELCET® (amphotericin b) is provided as a sterile, opaque suspension in 20 mL glass, single-use vials. Each 20 mL vial contains 100 mg of amphotericin B (see DOSAGE AND ADMINISTRATION), and each mL of ABELCET® contains:
Amphotericin B USP.......................................5 mgL-α-dimyristoylphosphatidylcholine (DMPC).......................................3.4 mg
L-α-dimyristoylphosphatidylglycerol (DMPG).......................................1.5 mg
Sodium Chloride USP.......................................9 mg
Water for Injection USP, q.s. 1 mL "
ONCOLOGY
Get Best QuoteRequest A Callback